Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-Label Extension Study

被引：0
|
作者：
Fernandez, Hubert H. [1 ]
Stamler, David [2 ]
Davis, Mat D. [2 ]
Factor, Stewart A. [3 ]
Hauser, Robert A. [4 ]
Jimenez-Shahed, Joohi [5 ]
Ondo, William G. [6 ,7 ]
Jarskog, L. Fredrik [8 ]
Woods, Scott W. [9 ]
LeDoux, Mark S. [10 ]
Shprecher, David R. [11 ]
Anderson, Karen E. [12 ]
机构：
[1] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA
[2] Teva Pharmaceut Ind, La Jolla, CA USA
[3] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[4] Movement Disorders Ctr, Tampa, FL USA
[5] Parkinsons Dis Ctr & Movement Disorders Clin, Houston, TX USA
[6] Methodist Neurol Inst, Houston, TX USA
[7] Weill Cornell Med Coll, Houston, TX USA
[8] Univ North Carolina, Sch Med, Chapel Hill, NC 27515 USA
[9] Yale Sch Med, New Haven, CT USA
[10] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[11] Banner Sun Hlth Res Inst, Sun City, AZ USA
[12] Georgetown Univ, Washington, DC USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.075
引用
收藏
页数：3
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [22] Levetiracetam in tardive dyskinesia: An open label study
    Konitsiotis, Spiros
    Pappa, Sofia
    Mantas, Christos
    Mavreas, Venos
    MOVEMENT DISORDERS, 2006, 21 (08) : 1219 - 1221
  • [23] Continued Evidence for Safety and Efficacy of Risedronate in Men with Osteoporosis: Outcome of the 2-year Open-Label Extension Study of MASTER.
    Boonen, S.
    Orwoll, E.
    Wenderoth, D.
    Stoner, K.
    Eusebio, R.
    Delmas, P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S464 - S464
  • [24] Effects of zonisamide on tardive dyskinesia : A preliminary open-label trial
    Iwata, Y.
    Irie, S.
    Uchida, H.
    Suzuki, T.
    Watanabe, K.
    Iwashita, S.
    Mimura, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 119 - 119
  • [25] Effects of zonisamide on tardive dyskinesia: A preliminary open-label trial
    Iwata, Yusuke
    Irie, Sachiko
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Watanabe, Koichiro
    Iwashita, Satoru
    Mimura, Masaru
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 315 (1-2) : 137 - 140
  • [26] EFFECT OF LURASIDONE ON COGNITION IN ADOLESCENTS WITH SCHIZOPHRENIA: INTERIM ANALYSIS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    Harvey, Philip D.
    Goldman, Robert
    Tocco, Michael
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S353 - S353
  • [27] TARDIVE-DYSKINESIA - 2-YEAR RECOVERY
    SEEMAN, MV
    COMPREHENSIVE PSYCHIATRY, 1981, 22 (02) : 189 - 192
  • [28] A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia
    Marder, Stephen R.
    Singer, Carlos
    Lindenmayer, Jean-Pierre
    Tanner, Caroline M.
    Comella, Cynthia L.
    Verghese, Cherian
    Jimenez, Roland
    Liang, Grace S.
    Burke, Joshua
    O'Brien, Christopher F.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 620 - 627
  • [29] Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia:: a 2-year, open-label extension study
    Luetjohann, D.
    von Bergmann, K.
    Sirah, W.
    Macdonell, G.
    Johnson-Levonas, A. O.
    Shah, A.
    Lin, J.
    Sapre, A.
    Musliner, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (10) : 1499 - 1510
  • [30] An Open-Label Pilot Study to Examine the Safety, Tolerability and Efficacy of Deutetrabenazine in Isolated Dystonia
    Deik, Andres
    Aamodt, Whitley
    Cadet, Christina
    Lasker, Aaron
    Oliver, Alexandria
    Spindler, Meredith
    Tropea, Thomas F.
    Vaswani, Pavan
    Siderowf, Andrew
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
12345